Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death

Neuroscience Letters

Volumn 263, Issue 2-3, 1999, Pages 153-156

  Gong, Li ^a   Jed Wyatt, Richard ^a   Baker, Ivory ^a   Masserano, Joseph M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Brain derived neurotrophic factor; CATH.a cells; Cell death; Dopamine; Glia cell line derived neurotrophic factor; Glutathione; Superoxide dismutase

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; FREE RADICAL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE; INSULIN; NERVE GROWTH FACTOR; NEUROTROPHIN 4; OXIDOPAMINE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOOXIDATION; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; ENZYME REPRESSION; MOUSE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; SCAVENGING SYSTEM;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; CELL LINE; CENTRAL NERVOUS SYSTEM; DOPAMINE; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE; INSULIN; KINETICS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; SUPEROXIDE DISMUTASE;

EID: 0344766113     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00148-2     Document Type: Article

References (20)

1. Cohen, G. and Heikkila, R., The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents, J. Biol. Chem., (1974) 2447-2452.
2. Duffy S., Austin S., Murphy T.H. Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. J. Neurochem. 71:1998;69-77.
3. Gabbay M., Tauber M., Porat S., Simantov R. Selective role of glutathione in protecting human neuronal cells from dopamine-induced apoptosis. Neuropharmacology. 35:1996;571-578.
4. Hoffer B.J., Hoffman A., Bownekamp K., Huettl P., Hudson J., Martin D., Lin L.-F.H., Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182:1994;107-111.
5. Hyman C., Juhasz M., Jackson C., Wright P., Ip N.Y., Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
6. Krieglstein K., Maysinger D., Unsicker K. The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-beta superfamily and characterization of the serum-free culture system. J. Neural. Transm. Suppl. 47:1996;247-258.
7. Louis J.-C., Magal E., Varon S. Receptor-mediated toxicity of norepinephrine on cultured catecholaminergic neurons of the rat brain stem. J. Pharmacol. Exp. Ther. 262:1992;1274-1283.
8. Masserano J.M., Gong L., Kulaga H., Baker I., Wyatt R.J. Dopamine induces apoptotic cell death of a catecholaminergic cell line derived from the central nervous system. Mol. Pharmacol. 50:1996;1309-1315.
9. Mena M.A., Khan U., Togasaki D.M., Sulzer D., Epstein C.J., Przedborski S. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J. Neurochem. 69:1997;21-33.
10. Offen D., Ziv I., Sternin H., Melamed E., Hochman A. Prevention of dopamine-induced cell death by thiol antioxidants: Possible implications for treatment of Parkinson's Disease. Exp. Neurol. 141:1996;32-39.
11. Ookawara, T., Kawamura, N., Kitagawa, Y. and Taniguchi, N., Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction, J. Biol. Chem., (1992) 18505-28510.
12. Salo D.C., Pacifici R.E., Lin S.W., Cecilia G., Davies J.A. Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J. Biol. Chem. 265:1990;11919-11927.
13. Shults C.W., Kimber T., Altar C.A. BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine. NeuroReport. 30:1995;1109-1112.
14. Smith C.S., Wyatt R.J., Masserano J.M. Nitric oxide induces cell death in a catecholaminergic cell line derived from the central nervous system. Neurosci. Lett. 241:1998;1-4.
15. Spencer J.P.E., Jenner P., Halliwell B. Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine: relevance to Parkinson's disease. NeuroReport. 6:1995;1480-1484.
16. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59:1992;99-106.
17. Suri C., Gung B.P., Tischler A.S., Chikaraishi D.M. Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J. Neurosci. 13:1993;1280-1291.
18. Tang F.I., Tien L.T., Zhou G.C., Hoffer B.J., Wang Y. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Exp. Brain Res. 119:1998;287-296.
19. Tomac A., Lindqvist V., Lin L.-F.H., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
20. Zawada W.M., Zastrow D.J., Clarkson E.D., Adams F.S., Bell K.P., Freed C.R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786:1998;96-103.